SEOUL, South Korea, Jan. 21, 2026 /PRNewswire/ -- Uncle Gurye, a premium food specialist based in South Korea, has announced the expansion of its Home Meal Replacement (HMR) lineup with the global launch of two new products: the Dried Herb Kit for Bibimbap and the Korean Savory Pancake Kit. Both products are crafted using pristine raw ingredients harvested from Korea's most renowned natural highlands.
By working closely with local Korean farms through contract farming, Uncle Gurye ensures the highest quality of produce. This direct partnership reinforces product reliability and supports the sustainable growth of Korea's agricultural communities.
Innovation in Convenience: No Soaking Required
The brand's flagship product, the Dried Herb Kit for Bibimbap, is the result of a precision-controlled process of washing, blanching, and specialized drying. This innovative method allows the herbs to be used immediately, eliminating the long preparation times traditionally associated with dried Korean vegetables.
- Effortless Preparation: Unlike conventional dried vegetables that require hours of soaking, these herbs can be cooked directly with rice. This allows anyone to enjoy a healthy, authentic bowl of bibimbap with minimal effort.
- Premium Korean Ingredients: The kit features carefully selected herbs such as Ssukbujaengi (Aster yomena), known for its unique aroma and health benefits, ensuring a deep and rich flavor for your bibimbap.
- Nutrient Retention: The specialized processing method minimizes nutrient loss, enabling health-conscious consumers to enjoy a nutrient-dense, traditional bibimbap even with a busy modern lifestyle.
Authentic Flavors Made Easy: Korean Savory Pancake Kit
The newly released Korean Savory Pancake Kit (Buchimgae) is designed to bring the quintessential taste of Korean soul food to kitchens around the world.
- Balanced Formulation: This pancake kit features an optimal blend of premium Korean herbs and high-quality pancake mix, ensuring a consistent flavor and a perfect crispy texture every time.
- Just Add Water: Preparing a delicious meal is simpler than ever; users only need to add water to the pancake kit. This convenience makes it an ideal choice for quick home meals or outdoor activities such as camping.
- Versatile Applications: The pancake kit serves as a perfect solution for those wanting to experience authentic Korean cuisine or for families looking for a healthy, vegetable-rich snack.
Commitment to Honest Food and Global Quality
Uncle Gurye adheres to strict hygiene standards and avoids chemical additives to preserve the natural, earthy taste of its ingredients. The company is dedicated to sharing the true value of Korean food culture through a transparent distribution network that connects Korean producers directly with global consumers.
"These products were developed to deliver the richness of Korea's natural herbs in the most convenient form," said a representative from Uncle Gurye. "Whether through our bibimbap kit or our pancake kit, we aim to provide honest, high-quality food that people everywhere can trust and enjoy."
Uncle Gurye's products are currently available through its official online store. The company plans to continue its research and development to further expand its lineup of herb-based HMR and Korean fusion food products.
▶ Official Website: http://www.guryeuncle.com/en/product
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Uncle Gurye Launches Premium Dried Herb Bibimbap and Korean Savory Pancake Kits Featuring Authentic Korean Ingredients
- Positioning Telangana among the world's top five life sciences clusters by 2030
- Targets USD 25 billion in investments
- Shifts focus from scale-led manufacturing to innovation-driven, value creation
DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India today unveiled its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum 2026 in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.
The policy articulates a decisive shift from scale-driven manufacturing to value-led, innovation-powered growth and positions Telangana as a globally integrated life sciences hub across discovery, development, and deployment. With a clear ambition to rank among the top five life sciences clusters worldwide by 2030, the policy targets USD 25 billion in investments, creation of 500,000 high-quality jobs, and deeper integration into global life sciences value chains.
The manufacturing depth is increasingly complemented by high-value R&D and innovation activity. Several global sciences organizations —including Amgen, Sanofi, Bristol Myers Squibb, Lilly, among several others have established or expanded R&D, digital, and global capability centres in Hyderabad, reflecting confidence in the Telangana's scientific talent and innovation-ready infrastructure.
The Next-Gen Life Sciences Policy 2026–30 represents a deliberate scale-up, designed to accelerate Telangana's transition from being indispensable to global supply chains to becoming a global originator of advanced therapies and platforms. The policy was unveiled by the Chief Minister Mr. A. Revanth Reddy in the presence of Minister for IT & Industries, Mr. D. Sridhar Babu, Special Chief Secretary Mr. Sanjay Kumar IAS, and CEO, Telangana Lifesciences, Mr. Shakthi M. Nagappan.
"We are building one of the world's most trusted and transformational biosciences ecosystems—driving global health impact from Telangana. The policy's global unveiling at Davos reflects Telangana's conviction that the next phase of growth in life sciences will be driven by cross-border collaboration, global capital, and shared innovation agendas." said Mr. A Revanth Reddy, Chief Minister of Telangana, India.
"The policy prioritizes frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across clinical research, pharma services, diagnostics, medical electronics and digital health—positioning Telangana as a preferred destination for global life sciences hubs" Mr. D. Sridhar Babu, Minister for IT, Electronics & Communications, and Industries, Government of Telangana
The policy implementation will be anchored by globally benchmarked infrastructure, including the Green Pharma City, ten Pharma Villages, expansion of Genome Valley, and further strengthening of the Medical Devices Park.
A dedicated Life Sciences Innovation Fund, scalable up to INR 1,000 crore (USD 100 million), will catalyze early- and growth-stage innovation, support deep-tech ventures, and crowd in private and institutional capital. This is supported by the establishment of the Telangana School of Life Sciences, a university of global excellence focused on research, education, and future-ready talent development.
About Telangana Life Sciences:
Telangana's aspiration is anchored in a mature, globally connected ecosystem that already operates at scale. Over the past two decades, the State has evolved from a manufacturing base into a full-spectrum life sciences hub spanning discovery research, clinical development, advanced manufacturing, and global operations.
Today, Telangana is home to over 2,000 life sciences companies, hosts one of the world's highest concentrations of USFDA-approved pharmaceutical facilities, supplies one-third of global vaccine demand, and serves as a trusted manufacturing and R&D partner to leading global life sciences companies. Companies in Hyderabad play a critical role in strengthening the resilience of global healthcare supply chains, particularly in vaccines, complex generics, biologics, and biosimilars.
DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India today unveiled its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum 2026 in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.
The policy articulates a decisive shift from scale-driven manufacturing to value-led, innovation-powered growth and positions Telangana as a globally integrated life sciences hub across discovery, development, and deployment. With a clear ambition to rank among the top five life sciences clusters worldwide by 2030, the policy targets USD 25 billion in investments, creation of 500,000 high-quality jobs, and deeper integration into global life sciences value chains.
The manufacturing depth is increasingly complemented by high-value R&D and innovation activity. Several global sciences organizations —including Amgen, Sanofi, Bristol Myers Squibb, Lilly, among several others have established or expanded R&D, digital, and global capability centres in Hyderabad, reflecting confidence in the Telangana's scientific talent and innovation-ready infrastructure.
The Next-Gen Life Sciences Policy 2026–30 represents a deliberate scale-up, designed to accelerate Telangana's transition from being indispensable to global supply chains to becoming a global originator of advanced therapies and platforms. The policy was unveiled by the Chief Minister Mr. A. Revanth Reddy in the presence of Minister for IT & Industries, Mr. D. Sridhar Babu, Special Chief Secretary Mr. Sanjay Kumar IAS, and CEO, Telangana Lifesciences, Mr. Shakthi M. Nagappan.
"We are building one of the world's most trusted and transformational biosciences ecosystems—driving global health impact from Telangana. The policy's global unveiling at Davos reflects Telangana's conviction that the next phase of growth in life sciences will be driven by cross-border collaboration, global capital, and shared innovation agendas." said Mr. A Revanth Reddy, Chief Minister of Telangana, India.
"The policy prioritizes frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across clinical research, pharma services, diagnostics, medical electronics and digital health—positioning Telangana as a preferred destination for global life sciences hubs" Mr. D. Sridhar Babu, Minister for IT, Electronics & Communications, and Industries, Government of Telangana
The policy implementation will be anchored by globally benchmarked infrastructure, including the Green Pharma City, ten Pharma Villages, expansion of Genome Valley, and further strengthening of the Medical Devices Park.
A dedicated Life Sciences Innovation Fund, scalable up to INR 1,000 crore (USD 100 million), will catalyze early- and growth-stage innovation, support deep-tech ventures, and crowd in private and institutional capital. This is supported by the establishment of the Telangana School of Life Sciences, a university of global excellence focused on research, education, and future-ready talent development.
Telangana's aspiration is anchored in a mature, globally connected ecosystem that already operates at scale. Over the past two decades, the State has evolved from a manufacturing base into a full-spectrum life sciences hub spanning discovery research, clinical development, advanced manufacturing, and global operations.
Today, Telangana is home to over 2,000 life sciences companies, hosts one of the world's highest concentrations of USFDA-approved pharmaceutical facilities, supplies one-third of global vaccine demand, and serves as a trusted manufacturing and R&D partner to leading global life sciences companies. Companies in Hyderabad play a critical role in strengthening the resilience of global healthcare supply chains, particularly in vaccines, complex generics, biologics, and biosimilars.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
